| 2934.20.15 | 00 | 2-Mercaptobenzothiazole; and N-(Oxydiethylene)benzothiazole-2-sulfenamide | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 52% |
| 2934.20.20 | 00 | 2-Mercaptobenzothiazole, sodium salt (2-Benzothiazolethiol, sodium salt) | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 2.8% (SG) | 15.4¡é/kg + 40% |
| 2934.20.25 | 00 | 2-Amino-5,6-dichlorobenzothiazole; 2-(4-Aminophenyl)-6-methylbenzothiazole-7- sulfonic acid; 2-Amino-6-nitrobenzothiazole; and N,N-Dicyclohexyl-2-benzothiazolesulfenamide | kg | Free | | 15.4¡é/kg + 52% |
| 2934.20.30 | 00 | 2-Amino-6-methoxybenzothiazole; 2-Amino-6-methylbenzothiazole; 6-Ethoxy-2-benzothiazolethiol; 3-Methylbenzothiazole-2-hydrazone; and Primuline base | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4¡é/kg + 39.5% |
| 2934.20.35 | 00 | Other: | | | | |
| 2934.20.40 | 00 | Other: | | | | |
| 2934.20.40 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2934.20.80 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 52% |
| 2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.30.12 | 00 | 2-(Trifluoromethyl)phenothiazine | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¡é/kg + 45% |
| 2934.30.18 | 00 | Ethyl (1H-phenothiazin-2,4,1)carbamate | kg | Free | | 15.4¡é/kg + 52% |
| 2934.30.23 | 00 | Other: | | | | |
| 2934.30.23 | 00 | Drugs: | | | | |
| 2934.30.23 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¡é/kg + 149.5% |
| 2934.30.27 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¡é/kg + 45% |
| 2934.30.43 | 00 | Other: | | | | |
| 2934.30.43 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2934.30.50 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 52% |
| 2934.91.00 | 00 | Other: | | | | |
| 2934.91.00 | 00 | Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof | kg | Free | | 15.4¡é/kg + 52% |
| 2934.99 | | Other: | | | | |
| 2934.99.01 | 00 | Aromatic or modified aromatic: | | | | |
| 2934.99.03 | 00 | 2-Acetylbenzo(b)thiophene; 3-Methylene-7-(2-phenoxyacetamido)- cephan-4-carboxylic acid, p-nitrobenzyl ester, 1-oxide; and Naphth[1,2-d]-[1,2,3]-oxadiazole-5-sulfonic acid and its sodium salt | kg | Free | | 15.4¡é/kg + 52% |
| 2934.99.05 | 00 | 5-Amino-3-phenyl-1,2,4-thiadiazole (3-Phenyl-5-amino-1,2,4-thiadiazole); 2-Hydroxybenzoxazole (Benzoxazolone); 4-Phenylmorpholine; 1,9-Thianthrenedicarboxylic acid; and Thioxanthene-9-one (Thioxanthone) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¡é/kg + 39.5% |
| 2934.99.06 | 00 | 7-Nitronaphth[1,2]oxadiazole-5-sulfonic acid and its salts | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4¡é/kg + 66.5% |
